Bosentan-induced Reduction in Cyclosporine-A Levels: A Rare Interaction in an Infant With Osteopetrosis and Severe Pulmonary Hyperetension

J Pediatr Hematol Oncol. 2015 Oct;37(7):573-4. doi: 10.1097/MPH.0000000000000409.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antihypertensive Agents / adverse effects*
  • Bosentan
  • Cyclosporine / blood*
  • Cyclosporine / therapeutic use
  • Drug Interactions
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Hypertension, Pulmonary / drug therapy*
  • Immunosuppressive Agents / blood*
  • Immunosuppressive Agents / therapeutic use
  • Infant
  • Male
  • Osteopetrosis / therapy*
  • Sulfonamides / adverse effects*

Substances

  • Antihypertensive Agents
  • Immunosuppressive Agents
  • Sulfonamides
  • Cyclosporine
  • Bosentan